In autoimmune diseases, the oral administration of antigens or modified antigens has been used in MS (myelin basic protein), uveitis (retinal antigens), rheumatoid arthritis (type II collagen) and T1D (insulin peptides). This evidence concerns the gene INS and type 1 diabetes mellitus.